Idenix Pharmaceuticals (IDIX) Misses Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts IDIX Hot Sheet
Price: $24.50 --0%
Financial Fact:
Research and development: 24.19M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 24.19M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Idenix Pharmaceuticals (NASDAQ: IDIX) reported Q2 EPS of ($0.43), $0.22 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Idenix Pharmaceuticals (IDIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Legence Corp. (LGN) Misses Q2 EPS by 58c
- Tapestry shares tumble despite earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
